We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.1B
AUM Growth
-$1.01B
Cap. Flow
-$635M
Cap. Flow %
-57.59%
Top 10 Hldgs %
36.04%
Holding
915
New
342
Increased
119
Reduced
101
Closed
281

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Healthcare 26.29%
3 Technology 9.65%
4 Industrials 7.84%
5 Consumer Discretionary 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEY icon
626
PUT
KeyCorp
KEY
$24.3B
$1K ﹤0.01%
+17,800
New +$413K
SAND
627
CALL
DELISTED
Sandstorm Gold
SAND
$1K ﹤0.01%
28,300
SNDX icon
628
PUT
Syndax Pharmaceuticals
SNDX
$1.82B
$1K ﹤0.01%
+10,000
New +$185K
TRIP icon
629
CALL
TripAdvisor
TRIP
$1.26B
$1K ﹤0.01%
40,000
-18,500
-32% -$567K
APPH
630
CALL
DELISTED
AppHarvest, Inc. Common Stock
APPH
$1K ﹤0.01%
+56,300
New +$301K
DIDI
631
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$1K ﹤0.01%
+300
New +$2.28K
ABUS icon
632
Arbutus Biopharma
ABUS
$907M
-249,215
Closed -$1.07M
ACAD icon
633
CALL
Acadia Pharmaceuticals
ACAD
$5.06B
-15,000
Closed -$3K
ACAD icon
634
Acadia Pharmaceuticals
ACAD
$5.06B
-5,121
Closed -$85K
ADI icon
635
CALL
Analog Devices
ADI
$187B
-34,200
Closed -$268K
ALNY icon
636
CALL
Alnylam Pharmaceuticals
ALNY
$29B
-16,400
Closed -$582K
ALNY icon
637
PUT
Alnylam Pharmaceuticals
ALNY
$29B
-15,000
Closed -$48K
APLS
638
CALL
DELISTED
Apellis Pharmaceuticals
APLS
-57,800
Closed -$3K
APLS
639
DELISTED
Apellis Pharmaceuticals
APLS
-57,889
Closed -$1.91M
APLS
640
PUT
DELISTED
Apellis Pharmaceuticals
APLS
-83,900
Closed -$611K
ASHR icon
641
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.59B
-10,000
Closed -$1K
AUPH icon
642
CALL
Aurinia Pharmaceuticals
AUPH
$2.06B
-53,900
Closed -$330K
AXON
643
CALL
Axon Enterprise
AXON
$48.4B
-20,000
Closed -$38K
BAC icon
644
Bank of America
BAC
$447B
-18,753
Closed -$796K
BBVA icon
645
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
-1,000,000
Closed -$6.59M
BEPC icon
646
Brookfield Renewable
BEPC
$6.17B
-47,994
Closed -$1.86M
BKSY icon
647
BlackSky Technology
BKSY
$1.17B
-2,250
Closed -$186K
BKSY icon
648
PUT
BlackSky Technology
BKSY
$1.17B
-2,250
Closed -$54K
BMY icon
649
CALL
Bristol-Myers Squibb
BMY
$132B
-20,000
Closed -$1K
BMY icon
650
PUT
Bristol-Myers Squibb
BMY
$132B
-35,000
Closed -$60K

Similar funds

Cowen and Company's Q4 2021 Portfolio in Review

As of Q4 2021, Cowen and Company held 915 positions worth $1.1B, down 48% from $2.11B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Cowen and Company withdrew a net $635M in Q4 2021, closing 281 positions and reducing 101 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $268M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Cowen and Company opened a new position in Churchill Capital Corp VI worth $34.2M.

  • Cowen and Company's largest Q4 2021 buy was Churchill Capital Corp VI: 3,494,970 shares worth $34.2M.
  • Cowen and Company added most to Social Capital Hedosophia Holdings Corp. VI in Q4 2021, an estimated $65.1M increase.
  • Cowen and Company's biggest Q4 2021 reduction was Invesco QQQ Trust, cutting an estimated $146M.
  • Cowen and Company fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2021, selling an estimated $268M.
  • Cowen and Company's ten largest holdings make up 36% of its $1.1B portfolio in Q4 2021.
  • Cowen and Company opened 342 new positions and closed 281 in Q4 2021.
  • Cowen and Company's portfolio value fell 48% quarter-over-quarter to $1.1B.

Based on Cowen and Company's 13F filing for Q4 2021, filed 14 Feb 2022.